Welcome to PsychU!

Unmet Needs In Agitation Associated With Alzheimer’s Dementia (AAD)

Loading Events

Thank You For Attending Today’s Webinar

Please tell us what you thought about today’s presentation by taking the survey below:

Unmet Needs In Agitation Associated With Alzheimer’s Dementia (AAD)

This is a virtual event for PsychU members in Kansas, Missouri, Nebraska, Iowa, South Dakota and Illinois.

This evidence-based review highlights important aspects of agitation associated with Alzheimer’s Dementia (AAD) for better understanding of the prevalence and challenges in diagnosis and explore the potential pathobiological correlations in AAD. Describes the clinical and humanistic burden and discusses current guidelines for nonpharmacological and pharmacological treatments of this complex and prominent complication of an already devastating disease. It underlines unmet needs for FDA-approved pharmaceutical treatments for agitation to improve care and quality of life for patients suffering from AAD.



Clayton Levret, PharmD (OPDC)

Medical Science Liaison

Clayton Levret received his PharmD from the University of Kansas. Post-graduation Clayton worked as a clinical pharmacist prior to joining the Otsuka FMA team.

Maria Perez, PharmD, AAHIVP (OPDC)

Medical Science Liaison

Speakers Clayton Levret, PharmD and Maria Perez, PharmD, AAHIVP are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)


Related Resources

Join today for instant access to all PsychU content, events, and more!

Membership is free!

Join PsychU Today to receive a wide array of tools and benefits

  • Join our multidisciplinary community that is improving mental health care… together
  • Quickly learn more about the topics you're interested in
  • Access an award-winning library of on-demand mental health resources
  • Gain key insights from industry expert & thought leaders